本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Caris Life Sciences, Inc.

28.50
+2.459.40%
盤後28.48-0.0197-0.07%19:59 EDT
成交量:884.24萬
成交額:2.46億
市值:80.41億
市盈率:76.61
高:28.68
開:25.80
低:25.80
收:26.05
52周最高:34.54
52周最低:14.19
股本:2.82億
流通股本:1.16億
量比:2.79
換手率:7.62%
股息:- -
股息率:- -
每股收益(TTM):0.3720
每股收益(LYR):-3.2200
淨資產收益率:20.13%
總資產收益率:8.77%
市淨率:13.59
市盈率(LYR):-8.85

資料載入中...

2021/03/01

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/16

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/03

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/02

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/12/31

重要事件披露

8-K - Current report
2020/12/29

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/06

重要事件披露

8-K - Current report
2020/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/10/29

重要事件披露

8-K - Current report
2020/09/14

重要事件披露

8-K - Current report
2020/08/17

重要事件披露

8-K - Current report
2020/08/07

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report